| Douglas Lee Vaupel, MD | |
|
1316 King St, Suite 3, Bellingham, WA 98229-6263 | |
| (360) 715-3088 | |
| (360) 715-3024 |
| Full Name | Douglas Lee Vaupel |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1316 King St, Bellingham, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992842710 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD00024595 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Douglas Lee Vaupel, MD 1316 King St, Suite 3, Bellingham, WA 98229-6263 Ph: (360) 715-3088 | Douglas Lee Vaupel, MD 1316 King St, Suite 3, Bellingham, WA 98229-6263 Ph: (360) 715-3088 |
News Archive
Sun Pharmaceutical Industries Ltd. today announced that the Hart-Scott-Rodino (HSR) Act waiting period in connection with the Tender Offer by Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida), a subsidiary of Sun, for all outstanding Ordinary Shares of Taro Pharmaceutical Industries Ltd. (Taro) expired on September 11, 2009. As of September 12, 2009, the HSR condition to the Offer is satisfied.
The U.S. Food and Drug Administration today approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor to Prevnar, the pneumococcal 7-valent conjugate vaccine licensed by the FDA in 2000 to prevent invasive pneumococcal disease (IPD) and otitis media. The new vaccine extends the protection to six additional types of the disease causing bacteria.
Researchers at Karolinska Institutet have shown how stem cells, together with other cells, repair damaged tissue in the mouse spinal cord. The results are of potential significance to the development of therapies for spinal cord injury.
In a new study, researchers found significant associations between seniors' long-term exposure to two types of air pollution and hospitalization for acute respiratory distress syndrome. The study was presented at the 2018 American Thoracic Society International Conference.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced top-line data for the company's randomized controlled trial (RCT) of PH-10 for mild-to-moderate plaque psoriasis.
› Verified 5 days ago
Mr. Ronald A Remick, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 609 N Shore Dr, Bellingham, WA 98226 Phone: 360-676-6000 Fax: 360-676-6006 | |
Dr. Neelam Kumari Sampley, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1133 Railroad Ave Ste 100, Bellingham, WA 98225 Phone: 916-835-0144 | |
Zachary Alan Webb, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1345 King St, Bellingham, WA 98229 Phone: 360-676-1696 Fax: 360-676-6636 | |
Ario H Hosseini, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1050 Larrabee Ave Ste 104-510, Bellingham, WA 98225 Phone: 360-200-8962 | |
Dr. Andrew Denzil Pauli, M.D Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1116 Key St Ste 200, Bellingham, WA 98225 Phone: 360-671-1369 Fax: 360-671-0981 | |
Danielle L Kizer, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2901 Squalicum Pkwy, Attn:behavioral Health Services, Bellingham, WA 98225 Phone: 360-788-6993 Fax: 360-715-6996 | |
Dr. James M Harle, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1112 11th Street, 301, Bellingham, WA 98225 Phone: 360-414-2222 Fax: 360-414-2220 |